Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/06/2007 | US7291715 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
11/06/2007 | US7291711 Mutant fluorescent protein derived from green and red flourescent protein for use as imaging and reporter tools in biological systems; imaging diagnostics |
11/06/2007 | US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension |
11/06/2007 | US7291702 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
11/06/2007 | US7291700 PRO4985 polypeptide |
11/06/2007 | US7291605 Methods of treating various cancers using melanoma differentiation associated protein-7 |
11/06/2007 | US7291604 Administering to tissue, such as blood vessel and active nucleic acids ; insertion of stents; cardiovascular disorders |
11/06/2007 | US7291588 Immunogenic detoxified mutant E. coli LT-A toxin |
11/06/2007 | US7291499 Transformed cell, method of screening anti-aging agent and anti-aging agent |
11/06/2007 | US7291498 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
11/06/2007 | US7291495 β-Secretase variant |
11/06/2007 | US7291492 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
11/06/2007 | US7291491 Polypeptides |
11/06/2007 | US7291490 Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin |
11/06/2007 | US7291489 Microorganisms and processes for enhanced production of pantothenate |
11/06/2007 | US7291486 for converting (R)-methylmalonyl to (S)-methylmalonyl CoA in a host cell; genetic engineering |
11/06/2007 | US7291485 Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors |
11/06/2007 | US7291484 Processes for culturing E1-immortalized cells to increase product yields |
11/06/2007 | US7291483 FGF-CX polynucleotide sequences and methods of producing same |
11/06/2007 | US7291482 Transgenic microorganism comprising heterologous nucleotide sequences under control antisense agents; tissue engineering and heterologous gene expression |
11/06/2007 | US7291464 Autocatalysis/yeast two-hybrid assay |
11/06/2007 | US7291462 TADG-15: an extracellular serine protease overexpressed in carcinomas |
11/06/2007 | US7291458 Leptin-mediated gene-induction |
11/06/2007 | US7291455 Detecting cancer in humans; obtain sample, measure viral expression in sample, compare to control, amplified levels of viral expression indicates cancer |
11/06/2007 | US7291454 Comprises antisense olignucleotides, ribozymes, DNA and guide sequences; animal models; genetic engineering; for use in drug screening |
11/06/2007 | US7291453 Isolating DNA or corresponding mRNA from a mutated Hepatitis B Virus and screening for mutations in the HBV DNA polymerase |
11/06/2007 | US7291452 Erythrovirus and its applications |
11/06/2007 | US7291339 Chimeric polypeptide comprising bifunctional activities for use in medical diagnostics and monitoring protein interaction |
11/06/2007 | US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits |
11/06/2007 | US7291330 MD-1 inhibitors as immune suppressants |
11/06/2007 | US7291329 Antibodies against PRO4406 |
11/06/2007 | US7291325 Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins |
11/06/2007 | CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
11/06/2007 | CA2363713C Lantibiotic |
11/06/2007 | CA2271388C Liposomes encapsulating polynucleotides operatively coding for immunogenic polypeptides |
11/06/2007 | CA2168011C Hybrid toxin |
11/06/2007 | CA2159614C Control of plant abscission and pod dehiscence |
11/06/2007 | CA2158486C Coamplification of target nucleic acids using volume exclusion agent, in reaction composition, test kit and test device useful therefor |
11/06/2007 | CA2113089C Universal donor cells |
11/06/2007 | CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications |
11/06/2007 | CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof |
11/01/2007 | WO2007124493A2 Methods and compositions for producing recombinant proteins using a gene for trna |
11/01/2007 | WO2007124376A2 Short interfering rna duplexes targeting an ires sequence and uses thereof |
11/01/2007 | WO2007124312A2 Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use |
11/01/2007 | WO2007124133A2 Methods and compositions based on shiga toxin type 1 protein |
11/01/2007 | WO2007124115A2 Compositions and methods for identifying inhibitors and activators of cyclic amp phosphodiesterases |
11/01/2007 | WO2007124065A1 Generation of recombinant dna by sequence-and ligation-independent cloning |
11/01/2007 | WO2007124019A2 Methods and products related to the transfer of molecules from blood to the mammary gland |
11/01/2007 | WO2007123999A2 Δ17 desaturases and their use in making polyunsaturated fatty acids |
11/01/2007 | WO2007123777A2 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses |
11/01/2007 | WO2007123771A2 Ige directed dna vaccination |
11/01/2007 | WO2007123489A1 Method for recombinant protein production in cho cells |
11/01/2007 | WO2007123484A1 Method for multiparallel construction of host/vector-systems for expression of proteins |
11/01/2007 | WO2007123407A1 Tomato plants having higher levels of resistance to botrytis |
11/01/2007 | WO2007123402A2 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene |
11/01/2007 | WO2007123391A1 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene. |
11/01/2007 | WO2007123295A1 Method for analyzing metabolites flux using converging ratio determinant and split ratio determinant |
11/01/2007 | WO2007123265A1 Method of detecting individual encapsulated influenza viruses, primer set for the detection and kit for the detection |
11/01/2007 | WO2007123258A1 Improved synthesis of hydrogen gas in genetically modified organisms by expression of oxidoreductases and ferredoxin, and improved hydrogenase activity and hydrogen synthesis in genetically modified organisms in the presence of oxygen with enhanced expression of e. coli isc-operon |
11/01/2007 | WO2007123233A1 Gene associated with arteriosclerotic disease, and use thereof |
11/01/2007 | WO2007123100A1 Filter-carrying micro plate |
11/01/2007 | WO2007123010A1 Agent for improving bone metabolism |
11/01/2007 | WO2007122975A1 Hgf precursor protein mutant and activated form thereof |
11/01/2007 | WO2007122940A1 Method of constructing artificially positive control dnas for multiplex pcr |
11/01/2007 | WO2007122823A1 Tumor target cell capable of producing vector |
11/01/2007 | WO2007122820A1 Diagnostic agent and therapeutic agent for pancreatic cancer |
11/01/2007 | WO2007122815A1 Bivalent antibody directed against bir1 |
11/01/2007 | WO2007122760A1 Detection reagent and detection method for influenza infection |
11/01/2007 | WO2007122405A1 Polyhedral nanostructures formed from nucleic acids |
11/01/2007 | WO2007122086A1 Transgenic plants and methods for controlling bolting in sugar beet |
11/01/2007 | WO2007121978A1 Antibody against the formation of haustoria as a crop protection agent against phytoparasites |
11/01/2007 | WO2007121946A2 Means for inhibiting the expression of cd31 |
11/01/2007 | WO2007121717A1 Formulations and method for isolating nucleic acids from complex starting materials and subsequent complex genetic analysis |
11/01/2007 | WO2007121522A1 Pestivirus species |
11/01/2007 | WO2007121512A1 Insect olfactory receptors |
11/01/2007 | WO2007097740A3 Sample preparation methods and devices |
11/01/2007 | WO2007089901A3 Metabolically engineered organisms for the production of hydrogen and hydrogenase |
11/01/2007 | WO2007087279A3 Methods for breeding glyphosate resistant plants and compositions thereof |
11/01/2007 | WO2007084954A3 Selective inhibition of ig20 splice variants to treat cancers |
11/01/2007 | WO2007083226A3 Method for selecting a peptide or polypeptide which binds to a target molecule |
11/01/2007 | WO2007064972A3 Monoclonal antibodies against amyloid beta protein and uses thereof |
11/01/2007 | WO2007064853A3 Locked nucleic acid oligonucleotides |
11/01/2007 | WO2007060514A3 Methods and compositions for modulating root growth in plants |
11/01/2007 | WO2007059473A3 Methods for the production and purification of adenoviral vectors |
11/01/2007 | WO2007056723A3 Detection of nucleic acids by target-specific hybrid capture method |
11/01/2007 | WO2007053661A3 Uses of anti-cd40 antibodies |
11/01/2007 | WO2007053358A3 Methods for identifying compounds of interest using encoded libraries |
11/01/2007 | WO2007035752A3 Low acrylamide foods |
11/01/2007 | WO2007027970A3 Prenatal diagnosis using cell-free fetal dna in amniotic fluid |
11/01/2007 | WO2007001684A3 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
11/01/2007 | WO2006138435A3 Methods for enhancing immune responses |
11/01/2007 | WO2005118820A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
11/01/2007 | WO2005079357A9 Nucleic acid representations utilizing type iib restriction endonuclease cleavage products |
11/01/2007 | WO2002079435A3 Transgenic mice containing gpcr-like gene disruptions |
11/01/2007 | WO2002040689A3 Expression of flavin-containing monooxygenases in plants |
11/01/2007 | US20070256198 Delayed Flowering Time Gene (DLF1) in Maize and Uses Thereof |
11/01/2007 | US20070256197 Exhibits endoglucanase or exoglucanase activity in the absence of scaffolding; combined with a beta-glucosidase, an alpha-amylase, or a glucoamylase; cellobiose is produced and contacted with beta-glucosidase, producing glucose; fermentation to produce ethanol, lactic acid, or acetone; biofuels |
11/01/2007 | US20070256196 Method of Modifying Plant Phenotypes With Nonsymbiotic Hemoglobin |
11/01/2007 | US20070256195 introducing into progenitor cells of the plant a plant transformation vector comprising a heterologous constitutive promoter operatively linked to a nucleotide sequence that encodes a HIO32.2 polypeptide, growing the cell to produce transgenic plant with an altered oil content phenotype |
11/01/2007 | US20070256194 Isolated nucleic acids encoding resistance polypeptides and uses thereof |